ARS Pharmaceuticals (SPRY) Stock Forecast & Price Target

$4.87

+0.05 (+1.04%)

(As of 01:57 PM ET)

Today's Range: $4.77
▼
$4.95
50-Day Range: $2.92
▼
$6.61
52-Week Range: $2.55
▼
$9.65

Volume: 271,390 shs
Average Volume: 978,915 shs
Market Capitalization: $467.52 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.67

ARS Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 4 Analyst Ratings

Analysts' Consensus Price Target

$14.67
201.16% Upside

High Forecast	$17.00
Average Forecast	$14.67
Low Forecast	$13.00

Type	Current Forecast 11/29/22 to 11/29/23	1 Month Ago 10/30/22 to 10/30/23	3 Months Ago 8/31/22 to 8/31/23	1 Year Ago 11/29/21 to 11/29/22
Consensus Rating	Hold	Hold	Buy	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	1 Buy rating(s)	1 Buy rating(s)	3 Buy rating(s)	N/A
Hold	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$14.67	$12.00	$15.33	N/A
Predicted Upside	201.16% Upside	123.36% Upside	105.72% Upside	N/A

Get ARS Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SPRY and its competitors with MarketBeat's FREE daily newsletter.

SPRY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SPRY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ARS Pharmaceuticals Stock vs. The Competition

Type	ARS Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.25	2.67	2.49
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	204.60% Upside	1,019.49% Upside	2,838.33% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/13/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$5.00 ➝ $13.00	+243.01%
9/21/2023	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Ruiz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
9/21/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
9/20/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Lugo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform

(Data available from 11/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

SPRY Price Target - Frequently Asked Questions

What is ARS Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 4 analysts in the last year, the consensus rating for ARS Pharmaceuticals stock is Hold based on the current 3 hold ratings and 1 buy rating for SPRY. The average twelve-month price prediction for ARS Pharmaceuticals is $14.67 with a high price target of $17.00 and a low price target of $13.00. Learn more on SPRY's analyst rating history.
Do Wall Street analysts like ARS Pharmaceuticals more than its competitors?: Analysts like ARS Pharmaceuticals less than other Medical companies. The consensus rating for ARS Pharmaceuticals is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how SPRY compares to other companies.
Is ARS Pharmaceuticals being downgraded by Wall Street analysts?: Over the previous 90 days, ARS Pharmaceuticals's stock had 3 downgrades by analysts.

Does ARS Pharmaceuticals's stock price have much upside?: According to analysts, ARS Pharmaceuticals's stock has a predicted upside of 152.55% based on their 12-month stock forecasts.
What analysts cover ARS Pharmaceuticals?: ARS Pharmaceuticals has been rated by Leerink Partnrs, SVB Leerink, Wedbush, and William Blair in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:SPRY) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial